Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management.

Hematol Transfus Cell Ther · 2021 · PMC7910181 · PMID 32475788

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

18 , 19 Conclusion The study concluded that the incorporation of the quantitative PCR test (BCR-ABL) is fundamental for adequate treatment of chronic myeloid leukemia in the country, and is extremely significant for patients with CML in Brazil.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.